Press Releases
NOTICE OF RESOLUTION TO APPOINT ADMINISTRATORS AND SUSPENSION OF TRADING IN THE COMPANY'S SHARES
LONDON, UNITED KINGDOM / ACCESSWIRE / May 16, 2024 / As announced on 15 April 2024, Horizonte Minerals Plc (AIM:HZM)(TSX:HZM) ("Horizonte" or the "Company") has been unable to secure interest in the full financing needed to complete its 100% owned Araguaia Nickel Project ("Araguaia" or the "Project"). After a period of discussions with secured creditors, and existing and new... (continue reading...)
LONDON, ENGLAND / ACCESSWIRE / May 16, 2024 / Argo Blockchain plc, a global leader in cryptocurrency mining (LSE:ARB)(NASDAQ: ARBK), announces that the Company's Q1 2024 results will be released on Thursday, 23 May 2024.
Argo will host a conference call to discuss its results at 10:00 ET / 15:00 BST on Thursday, 23 May 2024. The conference call is open to all existing and potential shareholders, and the live webcast of the call can be accessed via the Investor Meet... (continue reading...)
Calgary, Alberta--(Newsfile Corp. - May 16, 2024) - Arrow Exploration Corp. (AIM: AXL) (TSXV: AXL) ("Arrow" or the "Company"), the high-growth operator with a portfolio of assets across key Colombian hydrocarbon basins, is pleased to announce the spud of the Carrizales Norte B pad Horizontal Well 1 ("CNB HZ-1") on the Tapir Block in the Llanos Basin of Colombia.
The CNB HZ-1 well will develop the Ubaque formation which has been successfully delineated by the CN Q1 2024... (continue reading...)
Purchase of own shares
LONDON, UK / ACCESSWIRE / May 16, 2024 / The Company announces that on 15 May 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20... (continue reading...)
INDEPENDENT STUDY OF OVARIAN CANCER CTCS HARVESTED BY THE PARSORTIX SYSTEM HIGHLIGHTS POTENTIAL TO PREDICT PROGRESSION FREE SURVIVAL FOR DRUG TRIALS
The study investigated 123 metastatic ovarian cancer patients over two and a half years using the Parsortix system to assess 474 longitudinal patient samples
Downstream qPCR molecular analysis of the Parsortix harvest for ESR1 and ERCC1 genes may be an early predictor of progression free survival and cancer progression... (continue reading...)
More Press Releases
View Older Stories-
Flash News: OKX Ventures Ranked as #1 Crypto Venture Capital Investor in Q1 2024 with 31 Deals
-
barq and TerraPay Forge a Strategic Partnership
-
FUJIFILM Launches GFX 100S II Camera, GF 500mm Long Lens, X-T50 Camera, and XF 16-50mm Lens; YouTube Video First Look, Live Event and More Info at B&H Photo
-
GeNeuro Announces Last Patient Last Visit in its Post-COVID Trial and Confirms Top-Line Results by End of June 2024
-
CCF Signs an Agreement to Distribute Structured Products Issued by Morgan Stanley
-
Phonak Announces Global Brand Ambassador, Legendary Guitarist Paul Gilbert
-
AVP Reinforces Its Leadership Team: Warda Shaheen Joins AVP as a General Partner for the AVP Late Stage Fund in Europe, while Pedro Barros Takes on the Role of Partner in Charge of Investor Relations
-
Keytom Partners With 10 Leading Global Banks to Boost Seamless Payments for Clients
-
Lightweight, High Speed: Fujifilm Introduces FUJIFILM GFX100S II Mirrorless Digital Camera
-
Super Telephoto Powerhouse: Fujifilm Introduces FUJINON GF500mmF5.6 R LM OIS WR Lens
-
Calling All Creatives: Fujifilm Announces FUJIFILM X-T50 Mirrorless Digital Camera and FUJINON XF16-50mmF2.8-4.8 R LM WR Lens
-
MT Højgaard Holding A/S: Continued profitable growth in a slowing market
-
RUBIS: Company communication
-
IDEX Biometrics interim report for the first quarter of 2024
-
SAF production in France: Haffner Energy announces new strategic project
-
Weak first quarter
-
PARROT: 2024 FIRST-QUARTER BUSINESS
-
Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT
-
LIfT BioSciences Awarded Innovate UK Grant to Accelerate Product Development of New IMAN Cell Therapy Variants
-
Appointment of Joint Corporate Broker and Financial Adviser
-
Irish Residential Properties Sub-Fund 1: Form 8.3 - Irish Residential Properties REIT PLC
-
-
Transaction in Own Shares
-
Dividend payment ex-date of JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’
-
Fosun attends "Choose France" Summit for a third time
-
Skanska divests the first building of the office project Studio in Warsaw, Poland, for EUR 86M, about SEK 1 billion
-
A new breakthrough in thermal monocular----Pixfra Mile2 Series
-
SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch
-
REAL SIMPLE Teams Up with Pinterest for First-Ever Shoppable "Best & Brightest" Issue
-
XRP Healthcare Sponsors The Ehlers-Danlos Society, with Vital Support via its Prescription Savings Card
-
Genentech Reports Positive Phase Ib Results for Its Dual GLP-1/GIP Receptor Agonist CT-388 in People With Obesity
-
Multitude SE initiates a written procedure to request certain amendments to the terms of its subordinated capital notes
-
Multitude SE initiates a written procedure to request certain amendments to the terms of its senior bonds due 2025
-
Maisons du Monde: First quarter 2024 Sales
-
IDEX - Ex. Repair Issue Today
-
Multitude SE with continued strong growth at the start of 2024: EBIT increases by 31 percent to EUR 11.6 million
-
Multitude SE: The Board of Directors of Multitude SE has decided to start a share buyback programme
-
CGG Changes Name to Viridien
-
TCM Group A/S: Interim report Q1 2024
-
-
BGHL (EUR): NAV(s)
-
First quarter 2024 financial information
-
Consolidated interim report 1 January – 31 March 2024
-
BGHL (GBP): NAV(s)
-
Transaction in Own Shares
-
Vallourec First Quarter 2024 Results
-
KPS CAPITAL PARTNERS TO ACQUIRE INNOMOTICS FROM SIEMENS AG
-
BUREAU VERITAS - Bureau Veritas successfully completes an inaugural A3 rated (by Moody’s) bond issuance of EUR 500 million with a maturity in May 2036
-
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
-
Aegon appoints Duncan Russell to succeed Matt Rider as Chief Financial Officer